MyoVista Insights is the cloud-native ECG management hub. MyoVista wavECG is the purpose-built device. AI-ECG algorithms are validated through peer-reviewed research and surfaced through both.
A device-agnostic, cloud-native ECG management system. Centralizes ECGs from major manufacturers, runs FDA-cleared and partner AI-ECG models, and pipes results into Epic via the Epic TOOLBOX 2026 designation.
A 12-lead resting ECG built to host AI-ECG algorithms on-device. Combines conventional ECG diagnostics with proprietary continuous wavelet transform signal processing for AI analysis at the point of care.
MyoVista Insights and wavECG share the same underlying portfolio: algorithms targeting low ejection fraction, preserved ejection fraction, impaired cardiac relaxation, mitral valve regurgitation, aortic stenosis, pulmonary embolism, right-ventricular function, and more — each backed by peer-reviewed research.
See the clinical evidenceLow Ejection Fraction
Impaired Cardiac Relaxation
Aortic Stenosis
Pulmonary Embolism
See MyoVista Insights against your existing ECG workflow with our team.